Revenue, last quarter
$200.4M
−1.3% vs same quarter last year
Net income
$8.5M
−33.5% vs same quarter last year
EPS, diluted
$0.02
−50% vs same quarter last year
Operating cash flow
$80.8M
+63% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $796.9M | $30.4M |
| FY24 | $792.3M | $16.4M |
| FY23 | $750.3M | −$8.9M |
| FY22 | $766.6M | −$32.8M |
| FY21 | $745.4M | −$25.3M |
| FY20 | $550.7M | −$293.6M |
| FY19 | $388.2M | $66M |
| FY18 | $249.5M | $43.8M |
| FY17 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | 11% | 3.8% |
| FY24 | 8.3% | 2.1% |
| FY23 | −3.6% | −1.2% |
| FY22 | 0.2% | −4.3% |
| FY21 | 1.8% | −3.4% |
| FY20 | −50.1% | −53.3% |
| FY19 | 36% | 17% |
| FY18 | 31% | 17.6% |
| FY17 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $164.4M |
| FY24 | $182.7M |
| FY23 | $137.2M |
| FY22 | $142.8M |
| FY21 | $174.2M |
| FY20 | $110.8M |
| FY19 | $81.9M |
| FY18 | $44.4M |
| FY17 | - |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | - | $216.4M |
| FY24 | - | $158.8M |
| FY23 | - | $104M |
| FY22 | - | $101.7M |
| FY21 | - | $0 |
| FY20 | - | $0 |
| FY19 | - | - |
| FY18 | $1.3B | - |
| FY17 | - | - |
- GoodRx
- Technology median
Show the numbers
| Year | GoodRx | Technology median |
|---|---|---|
| FY25 | 3.8% | −2.3% |
| FY24 | 2.1% | −5% |
| FY23 | −1.2% | −6.7% |
| FY22 | −4.3% | −4.4% |
| FY21 | −3.4% | −1.7% |
| FY20 | −53.3% | −3% |
| FY19 | 17% | 0% |
| FY18 | 17.6% | 0.8% |
| FY17 | - | 2% |